ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

October 11, 2002

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

NCI Cooperative Group, Cancer Center Trials Listed

August 31, 2007

Tobaccos Council Awards New Grants

April 3, 1981

New Health Bills Could Affect Cancer Program

February 9, 1979

NIH reauthorization to be topic of July 19 hearing.

July 15, 2005